Literature DB >> 8532755

Limitations of a pencil beam approach to photon dose calculations in lung tissue.

T Knöös1, A Ahnesjö, P Nilsson, L Weber.   

Abstract

A common limitation in treatment planning systems for photon dose calculation is to ignore the impact on electron transport and photon scatter from patient heterogeneities. The heterogeneity correlation is often based on scaling operations along beam rays as for the method according to Batho or the more novel approach of 1D convolutions along beam paths applied in pencil-beam-based systems. The effects of the limitation have been studied in a mediastinum geometry for a wide range of beam qualities by comparing the results from a pencil-beam-based treatment planning system with the results from Monte Carlo calculations. As expected, the deviations within unit-density volumes are small while deviations in low-density volumes increase with increasing beam energy from approximately 3% for 4 MV to 14% for 18 MV x-rays as a result of increased electron disequilibrium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532755     DOI: 10.1088/0031-9155/40/9/002

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  17 in total

1.  Technical note: Heterogeneity dose calculation accuracy in IMRT: study of five commercial treatment planning systems using an anthropomorphic thorax phantom.

Authors:  Scott E Davidson; Richard A Popple; Geoffrey S Ibbott; David S Followill
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

2.  The importance of surrounding tissues and window settings for contouring of moving targets.

Authors:  Kai Joachim Borm; Markus Oechsner; Johannes Berndt; Stephanie Elisabeth Combs; Michael Molls; Marciana Nona Duma
Journal:  Strahlenther Onkol       Date:  2015-06-19       Impact factor: 3.621

3.  Pencil Beam Algorithms Are Unsuitable for Proton Dose Calculations in Lung.

Authors:  Paige A Taylor; Stephen F Kry; David S Followill
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-06-13       Impact factor: 7.038

4.  VMAT and step-and-shoot IMRT in head and neck cancer: a comparative plan analysis.

Authors:  Rolf Wiehle; Stefan Knippen; Anca-Ligia Grosu; Gregor Bruggmoser; Norbert Hodapp
Journal:  Strahlenther Onkol       Date:  2011-11-29       Impact factor: 3.621

5.  A column-generation-based method for multi-criteria direct aperture optimization.

Authors:  Ehsan Salari; Jan Unkelbach
Journal:  Phys Med Biol       Date:  2013-01-14       Impact factor: 3.609

6.  Quantification of proton dose calculation accuracy in the lung.

Authors:  Clemens Grassberger; Juliane Daartz; Stephen Dowdell; Thomas Ruggieri; Greg Sharp; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-11       Impact factor: 7.038

7.  Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms.

Authors:  Wataru Takahashi; Hideomi Yamashita; Naoya Saotome; Yoshio Iwai; Akira Sakumi; Akihiro Haga; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2012-02-09       Impact factor: 3.481

8.  Optimization of extracranial stereotactic radiation therapy of small lung lesions using accurate dose calculation algorithms.

Authors:  Barbara Dobler; Cornelia Walter; Antje Knopf; Daniella Fabri; Rainer Loeschel; Martin Polednik; Frank Schneider; Frederik Wenz; Frank Lohr
Journal:  Radiat Oncol       Date:  2006-11-29       Impact factor: 3.481

9.  Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital.

Authors:  Hideomi Yamashita; Wataru Takahashi; Akihiro Haga; Satoshi Kida; Naoya Saotome; Keiichi Nakagawa
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

10.  Fast 3D dosimetric verifications based on an electronic portal imaging device using a GPU calculation engine.

Authors:  Jinhan Zhu; Lixin Chen; Along Chen; Guangwen Luo; Xiaowu Deng; Xiaowei Liu
Journal:  Radiat Oncol       Date:  2015-04-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.